FoRx Therapeutics
Basel, CH · Founded 2019 · 35 employees on LinkedIn · 3 known investors
FoRx Therapeutics is a biotechnology company focused on oncology drug discovery and clinical development, targeting the DNA Damage Response (DDR) network with small molecule inhibitors. Its work centers on cancer therapeutics developed by a team with pharma and biotech backgrounds.
Founders & leadership
Investors · 3
Funding
SEC filings, press & company announcements$50M disclosed across 1 round · 2025
- $50MSeries ADec 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does FoRx Therapeutics do?
- FoRx Therapeutics is a biotechnology company focused on oncology drug discovery and clinical development, targeting the DNA Damage Response (DDR) network with small molecule inhibitors. Its work centers on cancer therapeutics developed by a team with pharma and biotech backgrounds.
- Who are FoRx Therapeutics's investors?
- FoRx Therapeutics's investors include M Ventures, Novartis Venture Fund, Pfizer Venture Investments.
- How much funding has FoRx Therapeutics raised?
- FoRx Therapeutics has disclosed $50M raised across 1 round.
- Where is FoRx Therapeutics headquartered?
- FoRx Therapeutics is headquartered in Basel, CH.